Peak Serum AST Is a Better Predictor of Acute Liver Graft Injury after Liver Transplantation When Adjusted for Donor/Recipient BSA Size Mismatch (ASTi)

<table>Significant reductions in one-year graft survival in patients with ASTi &gt;3,500 IU/L compared to patients with ASTi &lt;3,500 IU/L. Kaplan-Meier survival analysis showed the probability of primary graft outcome among patients who had a peak-adjusted AST (ASTi) of greater than 3,500 IU/L along with those who had ASTi of less than 3,500 IU/L. The probability of event-free graft survival at 1 year was 0.576 in the ASTi &gt;3,500 IU/L group and 0.487 in the ASTi &lt;3,500 IU/L group. There was a significant reduction in graft survival in ASTi &gt;3,500 IU/L group.</table>

Journal of Transplantation

fig4

Figure 4

Figure 4: Peak Serum AST Is a Better Predictor of Acute Liver Graft Injury after Liver Transplantation When Adjusted for Donor/Recipient BSA Size Mismatch (ASTi) 

Figure 4 | Peak Serum AST Is a Better Predictor of Acute Liver Graft Injury after Liver Transplantation When Adjusted for Donor/Recipient BSA Size Mismatch (ASTi) 